Natural Vascular Scaffold (NVS) Therapy

Summary

The NVS Therapy is being studied to evaluate the safety and efficacy of retention of acute luminal gain, leading to acute hemodynamic improvement in superficial femoral and popliteal arteries with reference vessel diameters between 3.5 and 7.0 mm and lesion lengths between 36 and 96mm. The system is intended for use in patients with de novo lesions in the superficial femoral and proximal popliteal arteries.

Timeline

Start

2017-05-25

Primary completion

2018-10-29

Completion

2018-10-29

Drugs

Indications